cyproheptadine has been researched along with beta-endorphin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graf, E; Hoerer, E; Laurian, L; Oberman, Z | 1 |
| Baba, S; Fujita, T; Hirata, Y; Matsukura, S; Nakashima, H; Taniguchi, H; Uchihashi, M | 1 |
| Luchitsky, EV; Slavnov, VN; Valueva, GV | 1 |
| Luchitskiĭ, EV; Slavnov, VN; Valueva, GV | 1 |
| Fujita, T; Hirata, Y; Ikeda, M; Nakashima, H; Tomita, M; Uchihashi, M | 1 |
| Bons, EG; Hackeng, WH; Lamberts, SW; Uitterlinden, P | 1 |
| Demura, H; Mouri, T; Sasaki, A; Shibasaki, T; Shizume, K; Suda, T; Tozawa, F | 1 |
| Dua, PR; Sharma, VL | 1 |
| Choi, YS; Kim, YH; Song, DK; Suh, HW | 1 |
| Chung, KM; Huh, SO; Kim, YH; Song, DK; Suh, HW | 1 |
10 other study(ies) available for cyproheptadine and beta-endorphin
| Article | Year |
|---|---|
Antiserotonergic inhibition of calcitonin-induced increase of beta-endorphin, ACTH, and cortisol secretion.
Topics: Adrenocorticotropic Hormone; Adult; beta-Endorphin; Calcitonin; Cyproheptadine; Female; Humans; Hydrocortisone; Male; Middle Aged; Propranolol; Radioimmunoassay; Reference Values; Serotonin Antagonists | 1988 |
Concomitant suppression of plasma ACTH- and beta-endorphin-like immunoreactivity by cyproheptadine, naloxone, and somatostatin in the ectopic ACTH syndrome.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; beta-Endorphin; Cyproheptadine; Endorphins; Humans; Lypressin; Male; Naloxone; Paraneoplastic Endocrine Syndromes; Somatostatin; Thymoma; Thymus Neoplasms | 1985 |
Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; beta-Endorphin; beta-Lipotropin; Cushing Syndrome; Cyproheptadine; Endorphins; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System | 1985 |
[Dynamics of beta-lipotropin and beta-endorphin levels in Itsenko-Cushing disease patients being treated with the antiserotonin preparation cyproheptadine (peritol) and chloditan].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; beta-Endorphin; beta-Lipotropin; Cushing Syndrome; Cyproheptadine; Drug Therapy, Combination; Endorphins; Female; Humans; Hydrocortisone; Hypoglycemia; Insulin; Male; Middle Aged; Mitotane | 1984 |
Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF)-induced ACTH release in a patient with Nelson's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Basal Metabolism; beta-Endorphin; Bromocriptine; Corticotropin-Releasing Hormone; Cyproheptadine; Endorphins; Female; Gonadotropin-Releasing Hormone; Humans; Lypressin; Nelson Syndrome; Pituitary Neoplasms; Thyrotropin-Releasing Hormone | 1984 |
Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary gland.
Topics: Adrenocorticotropic Hormone; Animals; beta-Endorphin; beta-Lipotropin; Cyproheptadine; Endorphins; Female; In Vitro Techniques; Pituitary Gland, Anterior; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Serotonin | 1983 |
Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
Topics: Adenoma; Adrenocorticotropic Hormone; beta-Endorphin; Corticotropin-Releasing Hormone; Cushing Syndrome; Cyproheptadine; Dose-Response Relationship, Drug; Endorphins; Humans; In Vitro Techniques; Peptides; Pituitary Gland; Radioimmunoassay; Reserpine | 1983 |
Peptidergic mechanisms in feeding behaviour.
Topics: Animals; Anti-Anxiety Agents; beta-Endorphin; Central Nervous System Depressants; Chlordiazepoxide; Cyproheptadine; Diazepam; Eating; Feeding Behavior; Female; Histamine Antagonists; Hypnotics and Sedatives; Male; Mice; Naloxone; Phenobarbital | 1995 |
Effects of intrathecally injected histamine receptor antagonists on the antinociception induced by morphine, beta-endorphin, and U50, 488H administered intrathecally in the mouse.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; beta-Endorphin; Cyproheptadine; Histamine H1 Antagonists; Histamine H2 Antagonists; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Pain; Pain Measurement; Piperidines; Pyrrolidines; Ranitidine; Receptors, Histamine H1; Receptors, Histamine H2; Receptors, Histamine H3; Spinal Cord | 1996 |
Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; beta-Endorphin; Cerebral Ventricles; Cyproheptadine; Enkephalin, D-Penicillamine (2,5)-; Histamine Antagonists; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Pain; Piperidines; Ranitidine; Receptors, Histamine H1; Receptors, Histamine H2; Receptors, Histamine H3; Receptors, Opioid; Spinal Cord | 1999 |